Gadolinium ethoxybenzyl-diethylenetriaminepentaacetic acid (Gd-EOB-DTPA) is a hepatocyte-specific, linear ionic contrast agent for MRI. In comparison to other linear contrast agents Gd-EOB-DTPA is excreted equally through liver and kidneys. This prospective longitudinal study investigates the signal intensity (SI) in the dentate nucleus (DN) on unenhanced T1-weighted images after repetitive application of Gd-EOB-DTPA. 46 patients were included into the study and 107 MRI examinations were performed. Statistical analysis of 25 patients showed no significant correlation between cumulative dose of Gd-EOB-DTPA and SI change and between the DN/Pons ratiolast and the mean DN/Pons ratiofirst. Subgroup analysis however revealed a significant correlation for one out of two readers. Gd-EOB-DTPA deposition could not be proven in the framework of this study.
Get full access to this article
View all access options for this article.
References
1.
KandaTI, KawaguchiK, KitajimaHK, TakenakaD. High Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-weighted MR Images: Relationship with Increasing Cumulative Dose of a Gadolinium-based Contrast Material. Radiology. 2014;270:834–41.
2.
IdéeJ-M, et al.Role of thermodynamic and kinetic parameters in gadolinium chelate stability. Journal of Magnetic Resonance Imaging: JMRI. 2009;30:1249–58.
3.
PortM, et al.Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review. Biometals: An international Journal on the role of Metal Ions in Biology, Biochemistry, and Medicine. 2008;21:69–490.
4.
ErranteY, et al.Progressive increase of T1 signal intensity of the dentate nucleus on unenhanced magnetic resonance images is associated with cumulative doses of intravenously administered gadodiamide in patients with normal renal function, suggesting dechelation. Investigative Radiology. 2014;49:685–90.
5.
RadbruchA, et al.Gadolinium retention in the dentate nucleus and globus pallidus is dependent on the class of contrast agent. Radiology. 2015;275:783–91.
6.
WeberlingLD, et al.Increased Signal Intensity in the Dentate Nucleus on Unenhanced T1-Weighted Images After Gadobenate Dimeglumine Administration. Investigative Radiology. 2015;50:743–8.
7.
RadbruchA, et al.High-Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-Weighted Images: Evaluation of the Macrocyclic Gadolinium-Based Contrast Agent Gadobutrol. Investigative Radiology. 2015;50:805–10.
8.
CaoY, HuangD, ShihQG, PrinceMR. Signal Change in the Dentate Nucleus on T1-Weighted MR Images After Multiple Administrations of Gadopentetate Dimeglumine Versus Gadobutrol. AJR. American Journal of Roentgenology. 2016;206:414–9.
9.
StojanovD, Aracki-TrenkicA, VojinovicS, Benedeto-StojanovD, LjubisavljevicS. Increasing signal intensitywithin the dentate nucleus and globus pallidus on unenhanced T1Wmagnetic resonance images in patientswith relapsing-remitting multiple sclerosis: correlation with cumulative dose of a macrocyclic gadolinium-based contrast agent, gadobutrol. Eur Radiol. 2015;1-9.
10.
AgrisJ, PietschH, BalzerT. What Evidence Is There That Gadobutrol Causes Increasing Signal Intensity within the Dentate Nucleus and Globus Pallidus on Unenhanced T1W MRI in Patients with RRMS?European Radiology. 2016;26:816–7.
11.
KandaT, ObaH, ToyodaK, FuruiS. Macrocyclic Gadolinium-Based Contrast Agents Do Not Cause Hyperintensity in the Dentate Nucleus. AJNR. American Journal of Neuroradiology (2016).
12.
VerlohN, et al.Liver fibrosis and Gd-EOB-DTPA-enhanced MRI: A histopathologic correlation. Scientific Reports. 2015;5:15408.
13.
WeinmannHJ, BauerH, FrenzelT, MuhlerA, EbertW. Mechanism of hepatic uptake of gadoxetate disodium. Academic Radiology. 1996;3(Suppl 2):S232–4.
14.
van MontfoortJE, et al.Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1. The Journal of Pharmacology and Experimental Therapeutics. 1999;290:153–7.
15.
van BeersBE, PastorCM, HussainHK. Primovist, Eovist: what to expect?Journal of Hepatology. 2012;57:421–9.
16.
TsudaN, MatsuiO. Cirrhotic rat liver: reference to transporter activity and morphologic changes in bile canaliculi–gadoxetic acid-enhanced MR imaging. Radiology. 2010;256:767–73.
17.
QuattrocchiCC, et al.Gadodiamide and Dentate Nucleus T1 Hyperintensity in Patients With Meningioma Evaluated by Multiple Follow-Up Contrast-Enhanced Magnetic Resonance Examinations With No Systemic Interval Therapy. Investigative Radiology. 2015;50:470–2.
18.
FrenzelT, LengsfeldP, SchirmerH, HütterJ, WeinmannH-J. Stability of Gadolinium-Based Magnetic Resonance Imaging Contrast Agents in Human Serum at 37°C. Investigative Radiology. 2008;43:817–28.
19.
JostG, et al.Signal Increase on Unenhanced T1-Weighted Images in the Rat Brain After Repeated, Extended Doses of Gadolinium-Based Contrast Agents: Comparison of Linear and Macrocyclic Agents. Investigative Radiology. 2016;51:83–9.
20.
RamalhoJ, et al.High Signal Intensity in Globus Pallidus and Dentate Nucleus on Unenhanced T1-weighted MR Images: Evaluation of Two Linear Gadolinium-based Contrast Agents. Radiology. 2015;276:836–44.
21.
RobertP, et al.T1-Weighted Hypersignal in the Deep Cerebellar Nuclei After Repeated Administrations of Gadolinium-Based Contrast Agents in Healthy Rats: Difference Between Linear and Macrocyclic Agents. Investigative Radiology. 2015;50:473–80.
22.
BjørnerudA, et al.Signal Enhancement of the Dentate Nucleus at Unenhanced MR Imaging after Very High Cumulative Doses of the Macrocyclic Gadolinium-based Contrast Agent Gadobutrol: An Observational Study. Radiology. 2017;285:434–44.
23.
KandaT, et al.Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass Spectroscopy. Radiology. 2015;276:228–32.
24.
McDonaldRJ, et al.Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging. Radiology. 2015;275:772–82.
25.
ChristensenKN, et al.Quantification of gadolinium in fresh skin and serum samples from patients with nephrogenic systemic fibrosis. Journal of the American Academy of Dermatology. 2011;64:91–6.
26.
MurataN, et al. Macrocyclic and Other Non-Group 1 Gadolinium Contrast Agents Deposit Low Levels of Gadolinium in Brain and Bone Tissue: Preliminary Results From 9 Patients With Normal Renal Function. Investigative Radiology (2016).
27.
KahnJ, et al. Is There Long-term Signal Intensity Increase in the Central Nervous System on T1-weighted Images after MR Imaging with the Hepatospecific Contrast Agent Gadoxetic Acid? A Cross-sectional Study in 91 Patients. Radiology. 2017;162535.
28.
IchikawaS, MotosugiU, OmiyaY, OnishiH. Contrast Agent-Induced High Signal Intensity in Dentate Nucleus on Unenhanced T1-Weighted Images: Comparison of Gadodiamide and Gadoxetic Acid. Investigative Radiology (2017).
